Biotech Stocks To Keep An Eye On – June 25th

Thermo Fisher Scientific, AbbVie, and Danaher are the three Biotech stocks to watch today, according to MarketBeat’s stock screener tool. Biotech stocks are shares of publicly traded companies that use living cells and biological processes to develop medical therapies, diagnostics, agricultural solutions and other products. Because their valuations often hinge on the success or failure of research pipelines, clinical trial results and regulatory approvals, these stocks tend to be more volatile than those of more established industries. Investors are attracted by the potential for breakthroughs carrying high returns, but they must also contend with elevated scientific and regulatory risk. These companies had the highest dollar trading volume of any Biotech stocks within the last several days.

Thermo Fisher Scientific (TMO)

Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases; and solutions include biosciences, genetic sciences, and bio production to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets.

NYSE TMO traded down $4.11 during trading hours on Wednesday, hitting $400.26. 815,992 shares of the company were exchanged, compared to its average volume of 1,942,739. Thermo Fisher Scientific has a 52-week low of $385.46 and a 52-week high of $627.88. The firm has a market cap of $151.10 billion, a price-to-earnings ratio of 23.48, a PEG ratio of 2.11 and a beta of 0.78. The company has a quick ratio of 1.38, a current ratio of 1.77 and a debt-to-equity ratio of 0.64. The company has a 50 day moving average of $410.92 and a two-hundred day moving average of $485.85.

AbbVie (ABBV)

AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals worldwide. The company offers Humira, an injection for autoimmune and intestinal Behçet's diseases, and pyoderma gangrenosum; Skyrizi to treat moderate to severe plaque psoriasis, psoriatic disease, and Crohn's disease; Rinvoq to treat rheumatoid and psoriatic arthritis, ankylosing spondylitis, atopic dermatitis, axial spondyloarthropathy, ulcerative colitis, and Crohn's disease; Imbruvica for the treatment of adult patients with blood cancers; Epkinly to treat lymphoma; Elahere to treat cancer; and Venclexta/Venclyxto to treat blood cancers.

AbbVie stock traded up $0.93 during mid-day trading on Wednesday, hitting $186.48. The company had a trading volume of 1,236,653 shares, compared to its average volume of 6,211,620. The stock has a market cap of $329.40 billion, a price-to-earnings ratio of 79.33, a PEG ratio of 1.22 and a beta of 0.50. AbbVie has a 1 year low of $163.52 and a 1 year high of $218.66. The company has a quick ratio of 0.64, a current ratio of 0.76 and a debt-to-equity ratio of 44.14. The business has a fifty day moving average of $185.46 and a 200 day moving average of $187.82.

Danaher (DHR)

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.

Danaher stock traded up $0.85 during mid-day trading on Wednesday, hitting $198.32. The company had a trading volume of 1,102,742 shares, compared to its average volume of 3,467,856. The stock has a market cap of $141.93 billion, a price-to-earnings ratio of 38.52, a PEG ratio of 2.76 and a beta of 0.77. Danaher has a 1 year low of $171.00 and a 1 year high of $281.70. The company has a quick ratio of 1.05, a current ratio of 1.43 and a debt-to-equity ratio of 0.31. The business has a fifty day moving average of $194.11 and a 200 day moving average of $209.06.